Several brokerages have updated their recommendations and price targets on shares of AppLovin (NASDAQ: APP) in the last few weeks: 10/28/2026 – AppLovin had its price target lowered by UBS Group from $790.00 to $414.00. They now have a “buy” rating on the stock. 10/28/2026 – AppLovin had its price target lowered by Royal Bank […]

Several analysts have recently updated their ratings and price targets for Everpure (NYSE: P): 10/19/2026 – Everpure was upgraded by Zacks Research from “hold” to “strong-buy”. 10/14/2026 – Everpure was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 10/12/2026 – Everpure had its “neutral” rating reaffirmed by Cantor Fitzgerald. 10/12/2026 – Everpure had […]

Several brokerages have updated their recommendations and price targets on shares of CommVault Systems (NASDAQ: CVLT) in the last few weeks: 10/28/2026 – CommVault Systems had its price target raised by DA Davidson from $185.00 to $210.00. They now have a “buy” rating on the stock. 10/28/2026 – CommVault Systems had its price target raised […]

Several brokerages have updated their recommendations and price targets on shares of PTC Therapeutics (NASDAQ: PTCT) in the last few weeks: 11/2/2026 – PTC Therapeutics had its price target raised by Citigroup from $108.00 to $109.00. They now have a “buy” rating on the stock. 10/31/2026 – PTC Therapeutics was downgraded by Wall Street Zen […]

A number of research firms have changed their ratings and price targets for DuPont de Nemours (NYSE: DD): 10/30/2026 – DuPont de Nemours had its “sell (d+)” rating reaffirmed by Weiss Ratings. 10/15/2026 – DuPont de Nemours had its price target lowered by Royal Bank Of Canada from $176.00 to $160.00. They now have an […]